Direct comparison
NIH Resubmission Intro vs. Response to Reviewers
NIH's 1-page resubmission Introduction and a journal response-to-reviewers letter look alike but differ in length, quoting, and structure.
Written and maintained by CASRAI Editorial Board
Last updated
Ask CASRAI · included with Regulatory Radar
Ask about NIH Resubmission Intro vs. Response to Reviewers
Ask CASRAI answers research-administration questions and cites the passages behind every claim — and says so when the corpus does not cover something, instead of guessing. It comes with a Regulatory Radar subscription at $29 a month, alongside the daily digest of regulatory changes and the dashboard of what changed.
150 questions a day, on this site, over the API, or inside your own tools through the CASRAI MCP server.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.
How do NIH Introduction to Application, Journal Response to Reviewers compare side by side?
The table below compares NIH Introduction to Application, Journal Response to Reviewers across 10 procurement-relevant dimensions, from what it responds to through recourse if you disagree.
Side-by-side comparison
| Dimension | NIH Introduction to Application | Journal Response to Reviewers |
|---|---|---|
| What it responds to | One synthesized Summary Statement (panel critique + criterion scores) | Multiple individually attributed reviewer reports |
| Length limit | Capped at 1 page (PHS 398 Research Plan Form, unless the funding opportunity's Table of Page Limits says otherwise) | No fixed length — as long as it takes to address every point |
| Quoting convention | Narrative summary; reviewer language is not quoted verbatim | Quote each reviewer's comment verbatim, then respond directly underneath |
| Coverage expectation | Triaged — prioritize concerns that most affected the score; minor points handled briefly | Exhaustive — every comment addressed, even trivial ones |
| Where changes are documented | Narrated at a high level in the Introduction; actual edits shown via change bars/bracketed text in the resubmitted Research Strategy | Cited by exact manuscript location (e.g., page/line) in the letter itself, alongside a tracked-changes manuscript |
| Formatting convention | Continuous narrative prose, organized by concern | Numbered comments; reviewer text visually distinguished (italics/shaded block) from author response |
| Submission mechanism | Attachment within the electronic grant application (ASSIST/Grants.gov Workspace/institutional system); becomes part of the permanent application record | Separate cover-letter file in the journal's manuscript system (e.g., ScholarOne, Editorial Manager); correspondence, not part of the manuscript itself |
| Audience continuity | May be read by a partly or fully different panel than the prior round — must stand alone | Usually read by the same reviewers who made the original requests |
| Allowed for a first-time submission? | No — only for resubmission or revision application types, or if the funding opportunity requires one | N/A — applies only after peer review, at the revise-and-resubmit stage |
| Recourse if you disagree | Separate NIH appeal process for the review itself (not part of the Introduction) | Respectfully decline within the letter, or a separate appeal letter to the editor if rejected |
Common questions
Common questions about NIH Introduction to Application vs Journal Response to Reviewers
Can I reuse language between an NIH Introduction and a journal response letter?
+
Rarely usefully. The underlying scientific changes can inform both, but the framing has to be rebuilt — the Introduction's triaged, non-quoting, one-page narrative and the response letter's exhaustive, verbatim-quoting, point-by-point structure are different enough that a direct copy-paste reads as out of place in either document.
Does NIH ever require verbatim quoting in a resubmission?
+
No. The Introduction responds to the Summary Statement's critique in narrative form; there generally isn't space within one page to quote review language verbatim. Journal response letters, by contrast, are expected to quote each reviewer's comment verbatim before responding.
What happens if an NIH Introduction goes over one page?
+
Unless the specific funding opportunity's Table of Page Limits states otherwise, the Introduction to Application may not exceed one page per NIH's application-guide instructions for the PHS 398 Research Plan Form; going over risks a noncompliance issue at receipt.
Is there an NIH equivalent of quoting a reviewer's exact words?
+
Not formally. Individual reviewers' critiques feed into the Summary Statement, but applicants respond to that already-synthesized panel record, not to itemized, separately attributed comments the way journal reviewer reports work.
